{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "8377506",
  "DateCompleted": {
    "Year": "1993",
    "Month": "10",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "08",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-4790",
      "JournalIssue": {
        "Volume": "54",
        "Issue": "1",
        "PubDate": {
          "Year": "1993",
          "Month": "Sep"
        }
      },
      "Title": "Journal of surgical oncology",
      "ISOAbbreviation": "J Surg Oncol"
    },
    "ArticleTitle": "Serum and immunohistochemical studies of NCC-ST-439 in breast cancer.",
    "Pagination": {
      "StartPage": "5",
      "EndPage": "8",
      "MedlinePgn": "5-8"
    },
    "Abstract": {
      "AbstractText": [
        "It has been thought that NCC-ST-439 antigen (ST-439) is a tumor-related carbohydrate antigen. The authors conducted serum and immunohistochemical studies to investigate the clinical significance of ST-439 in breast cancer. The level of serum ST-439 was elevated in advanced and recurrent breast cancers. In comparison with CEA and CA15-3, ST-439 was superior in sensitivity but inferior in specificity to these markers. The level of serum ST-439 showed no correlation with the levels of CEA or CA15-3. In the combination assay of these three markers, 80.6% of recurrent cases and 33.8% of primary cases were positive. Immunohistochemically, the expression of ST-439 was observed in 28.1% of noncancerous mammary duct epithelium and in 38.1% of the cancerous portion. From the above, we concluded that ST-439 was a tumor-related antigen and could be a tumor marker with high sensitivity in breast cancer."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Surgery II, Nagoya University School of Medicine, Japan."
          }
        ],
        "LastName": "Narita",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Funahashi",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Satoh",
        "ForeName": "Y",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Imai",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Takagi",
        "ForeName": "H",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Surg Oncol",
    "NlmUniqueID": "0222643",
    "ISSNLinking": "0022-4790"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Tumor-Associated, Carbohydrate"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Carcinoembryonic Antigen"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "ST 439 antigen, human"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Adenofibroma"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Antigens, Tumor-Associated, Carbohydrate"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Breast"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Breast Diseases"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Carcinoembryonic Antigen"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunohistochemistry"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Neoplasm Recurrence, Local"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ]
}